Inspire Medical Systems (NYSE:INSP) announced today that it entered into an accelerated share repurchase program worth $75 million. Minneapolis-based Inspire entered into the repurchase agreement with Goldman Sachs. It’s being completed pursuant to a previously announced $150 million share repurchase program authorized by the Inspire board. Inspire scheduled the termination of the accelerated share repurchase […]
Inspire Medical
Inspire Medical sales grow more than 30% in Street-beating Q3, full-year guidance raised
Inspire Medical Systems (NYSE:INSP) shares are up today on third-quarter results that came in ahead of the consensus forecast. Shares of INSP were up more than 3% to $199.42 apiece by the afternoon today. Yesterday evening, the Minneapolis-based developer of neurostimulation technology for treating sleep apnea reported profits of $18.5 million. That equals 60¢ per […]
The top 10 neurotech stories of the year so far
Across medtech, companies have continued to innovate through the first nine months of 2024, and that rings especially true in the neurotech space. Regulatory achievements, mergers and acquisitions, significant fundraising and more within neurotech have all been topics that garnered the interest of the MassDevice readers so far this year. We even have lists of some […]
Inspire Medical beats The Street in Q2, ups guidance
Inspire Medical Systems (NYSE: INSP) continues to report good news, as sales grow for the maker of implantable neuromodulation devices to treat sleep apnea. Minneapolis-based Inspire earned $9.8 million, or 32¢ per share, on $195.9 million in revenue for the quarter that ended June 30, 2024. That compares with a loss of $11.9 million, or […]
Inspire Medical wins FDA nod for next-gen sleep apnea neurostim
Inspire Medical Systems announced today that it received FDA approval for its Inspire V therapy system. Inspire V includes a next-generation neurostimulator and associated Bluetooth patient remote and physician programmer. It marks the latest innovation for the Minneapolis-based obstructive sleep apnea (OSA) treatment developer. The pacemaker-like device delivers mild electrical stimulation to the hypoglossal nerve, […]
Inspire Medical stock ticks up on 30% Q2 sales growth, increased guidance
Inspire Medical Systems today announced preliminary second-quarter results that include 30% year-over-year revenue growth. Shares of INSP grew more than 5% to $132.56 in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose slightly. The developer of neuromodulation tech for treating sleep apnea also […]
Inspire Medical COO steps down to take on CEO role at another medtech company
Inspire Medical Systems announced that Chief Operating Officer Philip Ebeling is resigning to take on a CEO role at a cardiology medtech company. The company said in an SEC filing that his decision to resign was not due to a dispute or disagreement with the company or its management. His resignation takes effect on […]
Inspire sleep apnea therapy wins CE mark under the MDR
Inspire Medical Systems announced today that its Inspire therapy has secured its CE mark under the EU’s Medical Device Regulation. Going into effect in 2021, the tighter regulations in the European Union have been a major challenge for medical device companies. With worries growing that medtech companies would pull products out of the EU because […]
Inspire Medical has a serious implantable pulse generator recall
The FDA labeled a recall of Inspire Medical Systems (NYSE:INSP) implantable pulse generators (IPGs) Class I, the most serious kind. Inspire initiated a recall of its IV IPG on June 17. The recall involves removing certain devices from where they are used or sold. It extends to 32 devices of the Model 3028 IPG. To […]
Inspire Medical stock sinks despite Q1 sales gain, guidance increase
Inspire Medical Systems shares are taking a massive hit today despite first-quarter results that beat Wall Street’s expectations. The day after the company’s after-market earnings release, shares of INSP were down more than 34% to $160.50 apiece. MassDevice’s MedTech 100 Index—which includes stocks of the world’s largest medical device companies—was down nearly 1%. The hit […]
10 new, innovative medical devices to watch for in 2024
By Senior Editor Danielle Kirsh and Associate Editor Sean Whooley Significant medical device launches are coming in 2024. Think pulsed field ablation, diabetes treatment tech, surgical robotics and more. Pulsed field ablation news took over at the end of 2023 and the start of 2024, with Medtronic and Boston Scientific garnering significant regulatory approvals. Surgical […]
